![]() |
|
|
Vol. 292, Issue 3, 1071-1079, March 2000
Departments of Nuclear Medicine (E.T.M.D., P.L., W.J.G.O.,
F.H.M.C., O.C.B.) and Internal Medicine (E.T.M.D., J.W.M.M.),
University Medical Centre St. Radboud, Nijmegen; Department of
Pharmaceutics (G.S.), Utrecht Institute for Pharmaceutical Sciences,
Utrecht University, Utrecht; and Department of Physiological Chemistry
(G.L.S.), University of Groningen, Groningen, the Netherlands
Sterically stabilized liposomes are considered promising carriers of
therapeutic agents because they can facilitate controlled release of
the drugs, thereby reducing drug-related toxicity and/or targeted
delivery of drugs. Herein, we studied the pharmacokinetics and
biodistribution of repeated injections of radiolabeled
polyethyleneglycol (PEG) liposomes. Weekly injections of
99mTc-PEG liposomes dramatically influenced the circulatory
half-life in rats. Biodistribution 4 h after the second dose
showed a significantly reduced blood content (from 52.6 ± 3.7 to
0.6 ± 0.1% injected dose (ID), P < .01)
accompanied by a highly increased uptake in the liver (from 8.1 ± 0.8 to 46.2 ± 9.8%ID, P < .01) and in the spleen (from 2.2 ± 0.2 to 5.3 ± 0.7%ID,
P < .01). At subsequent injections the effect was
less pronounced: after the fourth dose, the pharmacokinetics of the
radiolabel had almost returned to normal. The same phenomenon was
observed in a rhesus monkey, but not in mice. The enhanced blood
clearance of the PEG liposomes also was observed in rats after
transfusion of serum from rats that had received PEG liposomes 1 week
earlier, indicating that the enhanced blood clearance was caused by a
soluble serum factor. This serum factor was a heat-labile molecule that
coeluted on a size exclusion column with a 150-kDa protein. In summary,
i.v. administration of sterically stabilized PEG liposomes
significantly altered the pharmacokinetic behavior of subsequently
injected PEG liposomes in a time- and frequency-dependent manner. The
observed phenomenon may have important implications for the repeated
administration of sterically stabilized liposomes for targeted drug delivery.
This article has been cited by other articles:
![]() |
R. D. Arnold, D. E. Mager, J. E. Slack, and R. M. Straubinger Effect of Repetitive Administration of Doxorubicin-Containing Liposomes on Plasma Pharmacokinetics and Drug Biodistribution in a Rat Brain Tumor Model Clin. Cancer Res., December 15, 2005; 11(24): 8856 - 8865. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Semple, T. O. Harasym, K. A. Clow, S. M. Ansell, S. K. Klimuk, and M. J. Hope Immunogenicity and Rapid Blood Clearance of Liposomes Containing Polyethylene Glycol-Lipid Conjugates and Nucleic Acid J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1020 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sakai, Y. Masada, H. Horinouchi, E. Ikeda, K. Sou, S. Takeoka, M. Suematsu, M. Takaori, K. Kobayashi, and E. Tsuchida Physiological Capacity of the Reticuloendothelial System for the Degradation of Hemoglobin Vesicles (Artificial Oxygen Carriers) after Massive Intravenous Doses by Daily Repeated Infusions for 14 Days J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 874 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Li, L. D. Mayer, and M. B. Bally Prevention of Antibody-Mediated Elimination of Ligand-Targeted Liposomes by Using Poly(Ethylene glycol)-Modified Lipids J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 976 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Laverman, M. G. Carstens, O. C. Boerman, E. Th. M. Dams, W. J. G. Oyen, N. van Rooijen, F. H. M. Corstens, and G. Storm Factors Affecting the Accelerated Blood Clearance of Polyethylene Glycol-Liposomes upon Repeated Injection J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 607 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Moghimi, A. C. Hunter, and J. C. Murray Long-Circulating and Target-Specific Nanoparticles: Theory to Practice Pharmacol. Rev., June 1, 2001; 53(2): 283 - 318. [Abstract] [Full Text] [PDF] |
||||